Lyell Immunopharma, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Lyell Immunopharma, Inc.LYEL5d

   Aguirre Jarrad Mattieu sold shares

   • Sold 422 shares on 10/12/2026
   • Price per share: $8.63
   • Owned 19,857 shares after transaction

   Jarrad Mattieu Aguirre, reporting

2. ROUTINE4Lyell Immunopharma, Inc.LYELSep 10

   3 insider filings

   David Shook, insider filing for LYEL

   Show all 3

   • 4Insider filing for LYELSep 10
   • 4Insider filing for LYELSep 10
   • 3New insider at LYELSep 10

   David Shook, reporting

3. ROUTINE8-KLyell Immunopharma, Inc.LYELSep 10

   Current report

4. ROUTINE4Lyell Immunopharma, Inc.LYELAug 25

   3 insider filings

   Lynn Seely, insider filing for LYEL

   Show all 3

   • 4Insider filing for LYELAug 25
   • 4Insider filing for LYELAug 25
   • 4Insider filing for LYELAug 25

   Lynn Seely, reporting

5. ROUTINESCHEDULE 13G/ALyell Immunopharma, Inc.LYELAug 14

   Ownership stake disclosure by Foresite Capital Fund IV, L.P. (amended)

   Foresite Capital Fund IV, L.P., filed by

6. ROUTINE4Lyell Immunopharma, Inc.LYELAug 11

   4 insider filings

   Veronica Sanchez Bulis, insider filing for LYEL

   Show all 4

   • 4Insider filing for LYELAug 11
   • 4Insider filing for LYELAug 11
   • 4Insider filing for LYELAug 11
   • 4Insider filing for LYELAug 11

   Veronica Sanchez Bulis, reporting

7. NOTABLE10-QLyell Immunopharma, Inc.LYELAug 6

   Quarterly report

8. ROUTINE8-KLyell Immunopharma, Inc.LYELAug 6

   Current report

9. ROUTINE4Lyell Immunopharma, Inc.LYELJul 27

   Innovative Cellular Therapeutics Holdings Ltd, insider filing for LYEL

   Innovative Cellular Therapeutics Holdings Ltd, reporting

10. ROUTINE4Lyell Immunopharma, Inc.LYELJul 27

    Innovative Cellular Therapeutics Holdings Ltd, insider filing for LYEL

    Innovative Cellular Therapeutics Holdings Ltd, reporting

11. ROUTINEEFFECTLyell Immunopharma, Inc.LYELJul 22

    Registration declared effective

12. ROUTINE4Lyell Immunopharma, Inc.LYELJul 20

    Innovative Cellular Therapeutics Holdings Ltd, insider filing for LYEL

    Innovative Cellular Therapeutics Holdings Ltd, reporting

13. ROUTINE4Lyell Immunopharma, Inc.LYELJul 17

    Innovative Cellular Therapeutics Holdings Ltd, insider filing for LYEL

    Innovative Cellular Therapeutics Holdings Ltd, reporting

14. ROUTINES-3Lyell Immunopharma, Inc.LYELJul 13

    Securities offering

15. ROUTINE4Lyell Immunopharma, Inc.LYELJul 1

    Innovative Cellular Therapeutics Holdings Ltd, insider filing for LYEL

    Innovative Cellular Therapeutics Holdings Ltd, reporting

16. ROUTINE4Lyell Immunopharma, Inc.LYELJun 18

    Innovative Cellular Therapeutics Holdings Ltd, insider filing for LYEL

    Innovative Cellular Therapeutics Holdings Ltd, reporting

17. ROUTINESCHEDULE 13G/ALyell Immunopharma, Inc.LYELJun 18

    Ownership stake disclosure by Innovative Cellular Therapeutics Holdings Ltd (amended)

    Innovative Cellular Therapeutics Holdings Ltd, filed by

18. ROUTINE3Lyell Immunopharma, Inc.LYELJun 18

    Innovative Cellular Therapeutics Holdings Ltd, new insider at LYEL

    Innovative Cellular Therapeutics Holdings Ltd, reporting

19. ROUTINE4Lyell Immunopharma, Inc.LYELJun 15

    4 insider filings

    Lynn Seely, insider filing for LYEL

    Show all 4

    • 4Insider filing for LYELJun 15
    • 4Insider filing for LYELJun 15
    • 4Insider filing for LYELJun 15
    • 4Insider filing for LYELJun 15

    Lynn Seely, reporting

20. ROUTINE8-KLyell Immunopharma, Inc.LYELJun 15

    Current report

21. ROUTINE4Lyell Immunopharma, Inc.LYELJun 12

    7 insider filings

    William Jl Rieflin, insider filing for LYEL

    Show all 7

    • 4Insider filing for LYELJun 12
    • 4Insider filing for LYELJun 12
    • 4Insider filing for LYELJun 12
    • 4Insider filing for LYELJun 12
    • 4Insider filing for LYELJun 12
    • 4Insider filing for LYELJun 12
    • 4Insider filing for LYELJun 12

    William Jl Rieflin, reporting

22. ROUTINE4Lyell Immunopharma, Inc.LYELJun 11

    David Shook, insider filing for LYEL

    David Shook, reporting

23. ROUTINESCHEDULE 13G/ALyell Immunopharma, Inc.LYELMay 15

    Ownership stake disclosure by ARCH Venture Fund IX, L.P. (amended)

    ARCH Venture Fund IX, L.P., filed by

24. ROUTINESCHEDULE 13G/ALyell Immunopharma, Inc.LYELMay 11

    Ownership stake disclosure by MWG Caph Ltd (amended)

    MWG Caph Ltd, filed by

25. ROUTINESCHEDULE 13G/ALyell Immunopharma, Inc.LYELMay 8

    Ownership stake disclosure by Explore Investments LLC/DE (amended)

    Explore Investments LLC/DE, filed by

26. NOTABLE10-QLyell Immunopharma, Inc.LYELMay 6

    Quarterly report

27. ROUTINE8-KLyell Immunopharma, Inc.LYELMay 6

    Current report

28. ROUTINEARSLyell Immunopharma, Inc.LYELApr 24

    Annual report to shareholders

29. ROUTINEDEFA14ALyell Immunopharma, Inc.LYELApr 24

    Additional proxy materials

30. ROUTINEDEF 14ALyell Immunopharma, Inc.LYELApr 24

    Proxy statement

31. ROUTINESCHEDULE 13GLyell Immunopharma, Inc.LYELApr 21

    Ownership stake disclosure by Euler Fund, L.P.

    Euler Fund, L.P., filed by

32. ROUTINEEFFECTLyell Immunopharma, Inc.LYELApr 15

    Registration declared effective

33. ROUTINES-3Lyell Immunopharma, Inc.LYELApr 3

    Securities offering

34. ROUTINE4Lyell Immunopharma, Inc.LYELMar 16

    Smital Shah, insider filing for LYEL

    Smital Shah, reporting

Older filings on EDGAR